• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PRIME; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PRIME; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1011707-38
Device Problems Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/18/2019
Event Type  malfunction  
Manufacturer Narrative
Exemption number (b)(4) permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported that the procedure was performed to treat a heavily tortuous and heavily calcified lesion in the mid left anterior descending artery.Resistance with the anatomy was felt when advancing a 2.5x38mm xience prime stent delivery system (sds).The sds was removed; however, resistance with the anatomy was felt and force was applied.The shaft separated and was simply withdrawn.The procedure was successfully completed with a new 2.5x38mm xience prime sds.There was no reported adverse patient effect or a clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.Device code 2017 - excessive force.The device was returned for analysis.The reported difficult to advance and the reported difficult to remove were able to be confirmed.The reported material separation was confirmed.A review of the manufacturing records identified no nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history revealed no other incidents.The xience prime instructions for use states: applying excessive force to the delivery system can potentially result in loss or damage to the stent and / or delivery system components.Although it was noted that physical resistance was met during retraction of the stent delivery system, this was due to the challenging anatomy; therefore the force applied during removal of the device seemed to be a reasonable clinical response to the difficulties.The investigation determined the reported failure to advance and difficult to remove appear to be related to procedural circumstances as it is likely that the device interacted with the challenging anatomy during advancement resulting in the reported failure to advance.Further interaction with the challenging anatomy during retraction of the device, as resistance was noted, likely contributed to the material separation.Based on the information reviewed and analysis of the returned device, there is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
 
Event Description
Subsequent to the previously filed report, additional information was received reporting that the shaft separated at the proximal end.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8783137
MDR Text Key150850357
Report Number2024168-2019-10045
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/26/2022
Device Catalogue Number1011707-38
Device Lot Number9021541
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/15/2019
Date Manufacturer Received09/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-